Spectra Optia® — apheresis system
Terumo BCT

Spectra Optia® — apheresis system


Short description

Spectra Optia® is a multifunctional automated system for therapeutic apheresis, collection and processing of blood cells. The device is designed for use in clinics, blood centers, and transfusion units where high precision procedures, patient safety, and a wide range of clinical capabilities are required.

The system combines technologies of continuous centrifugation, optical control of the separation of blood components and intelligent software control, providing stable and reproducible clinical results.

Scope of application

  • Transfusiology and Blood centers
  • Hematology and Oncology
  • Transplantation
  • Intensive care units
  • Clinical and scientific medical institutions

Appointment and procedures performed

Spectra Optia is designed to perform a wide range of apheretic and cellular procedures, including:

  • therapeutic plasmapheresis and plasma exchange;
  • erythrocytopheresis and erythrocyte exchange;
  • thrombocytopheresis and leukocytopheresis;
  • collection of mononuclear cells, including hematopoietic stem cells;
  • collection of granulocytes;
  • bone marrow processing and specialized cellular procedures.

Key advantages

  • A universal platform for therapeutic and donor apheresis
  • High precision separation and output of target components
  • Stability and reproducibility of clinical results
  • High level of automation and reduced operator workload
  • Increased patient safety at all stages of the procedure

Advanced separation technology

  • Continuous centrifugation with automatic control of the separation boundary of blood components.
  • Optical fraction recognition system to improve the accuracy and stability of procedures.
  • Minimizing losses of target components and optimizing product output.

Automation and control

  • Intuitive touch interface with real-time parameter display.
  • Preset and configurable protocols for various clinical tasks.
  • Automatic control of the key stages of the procedure.

Patient safety and comfort

  • Control of circulating blood volume and fluid balance.
  • Precise dosage of anticoagulant.
  • The use of disposable circuits with low extracorporeal volume, reducing the physiological load

Who is it intended for

  • Blood centers and Transfusion services
  • Hematology and oncology clinics
  • Transplant centers
  • Multidisciplinary medical institutions
  • Scientific research organizations

Compliance with standards

  • Compliance with international quality and safety requirements
  • Support of clinical protocols and standards of transfusion medicine

 

Documentation